“Immunology and Innate Immunity are Keys to Cancer Treatment” Conclusions of the Roundtable of internationally renowned speakers, including winners of the 2011 Nobel Prize in Medicine

Immunotherapy and innate immunity targets are at the heart of the search for long-term, high quality of life responses for patients

Bristol-Myers Squibb France and Innate Pharma are pleased to announce that the roundtable "Innate immunity: from revolutionary discovery to revolution in therapy", held on 15 May in Paris was a great success, with the participation of more than 150 international guests from across medical and scientific fields. The panel of internationally renowned speakers included special guests Bruce Beutler and Jules Hoffman, winners of the 2011 Nobel Prize in Medicine. The event highlighted the recent successes of immunotherapies and the significant therapeutic potential of targeting innate immunity.

Webcast, interviews, summary and more on www.immunite‐innee.com